Author:
Ohara Hiroshi,Nakamura Yuji,Watanabe Yudai,Cao Xin,Yamazaki Yukiko,Izumi-Nakaseko Hiroko,Ando Kentaro,Yamazaki Hiroshi,Yamazaki Junichi,Ikeda Takanori,Sugiyama Atsushi
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Toxicology,Molecular Biology
Reference28 articles.
1. Parnham, M. J., Haber, V. E., Giamarellos-Bourboulis, E. J., Perletti, G., Verleden, G. M., & Vos, R. (2014). Azithromycin: Mechanisms of action and their relevance for clinical applications. Pharmacology & Therapeutics, 143, 225–245.
2. Ray, W. A., Murray, K. T., Hall, K., Arbogast, P. G., & Stein, C. M. (2012). Azithromycin and the risk of cardiovascular death. New England Journal of Medicine, 366, 1881–1890.
3. Thomsen, M. B., Beekman, J. D., Attevelt, N. J., Takahara, A., Sugiyama, A., Chiba, K., et al. (2006). No proarrhythmic properties of the antibiotics moxifloxacin or azithromycin in anaesthetized dogs with chronic-AV block. British Journal of Pharmacology, 149, 1039–1048.
4. Santos, N., Oliveira, M., Galrinho, A., Oliveira, J. A., Ferreira, L., & Ferreira, R. (2010). QT interval prolongation and extreme bradycardia after a single dose of azithromycin. Revista Portuguesa de Cardiologia, 29, 139–142.
5. Huang, B. H., Wu, C. H., Hsia, C. P., & Yin Chen, C. (2007). Azithromycin-induced torsade de pointes. Pacing and Clinical Electrophysiology, 30, 1579–1582.
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献